These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1228 related articles for article (PubMed ID: 29976660)

  • 21. Cellular microRNAs 498 and 320d regulate herpes simplex virus 1 induction of Kaposi's sarcoma-associated herpesvirus lytic replication by targeting RTA.
    Yan Q; Li W; Tang Q; Yao S; Lv Z; Feng N; Ma X; Bai Z; Zeng Y; Qin D; Lu C
    PLoS One; 2013; 8(2):e55832. PubMed ID: 23418466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Expression and Nuclear Retention Element of Polyadenylated Nuclear RNA Is Not Required for Productive Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.
    Gutierrez IV; Dayton J; Harger S; Rossetto CC
    J Virol; 2021 Jun; 95(13):e0009621. PubMed ID: 33853955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling.
    Zeng Y; Zhang X; Huang Z; Cheng L; Yao S; Qin D; Chen X; Tang Q; Lv Z; Zhang L; Lu C
    J Virol; 2007 Mar; 81(5):2401-17. PubMed ID: 17151125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
    Smith CG; Kharkwal H; Wilson DW
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of heat shock protein 90 inhibitors on apoptosis and viral replication in primary effusion lymphoma cells.
    Higashi C; Saji C; Yamada K; Kagawa H; Ohga R; Taira T; Fujimuro M
    Biol Pharm Bull; 2012; 35(5):725-30. PubMed ID: 22687408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway.
    Li W; Jia X; Shen C; Zhang M; Xu J; Shang Y; Zhu K; Hu M; Yan Q; Qin D; Lee MS; Zhu J; Lu H; Krueger BJ; Renne R; Gao SJ; Lu C
    Oncotarget; 2016 May; 7(22):32286-305. PubMed ID: 27058419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of new antiviral agents against Kaposi's sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation.
    Chen J; Dai L; Goldstein A; Zhang H; Tang W; Forrest JC; Post SR; Chen X; Qin Z
    PLoS Pathog; 2019 Dec; 15(12):e1008156. PubMed ID: 31790497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FoxO1 Suppresses Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication and Controls Viral Latency.
    Gao R; Li T; Tan B; Ramos da Silva S; Jung JU; Feng P; Gao SJ
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30404794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
    Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RUNX3 inhibits KSHV lytic replication by binding to the viral genome and repressing transcription.
    Ren P; Niu D; Chang S; Yu L; Ren J; Ma Y; Lan K
    J Virol; 2024 Feb; 98(2):e0156723. PubMed ID: 38197631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
    Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M
    J Virol; 2017 May; 91(10):. PubMed ID: 28275189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency.
    Ye F; Zhou F; Bedolla RG; Jones T; Lei X; Kang T; Guadalupe M; Gao SJ
    PLoS Pathog; 2011 May; 7(5):e1002054. PubMed ID: 21625536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Latency-associated nuclear antigen inhibits lytic replication of Kaposi's sarcoma-associated herpesvirus by regulating let-7a/RBPJ signaling.
    Qi Y; Zheng G; Di C; Zhang J; Wang X; Hong Y; Song Y; Chen R; Yang Y; Yan Y; Xu L; Tan X; Yang L
    Virology; 2019 May; 531():69-78. PubMed ID: 30856484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs Target GADD45B To Protect Infected Cells from Cell Cycle Arrest and Apoptosis.
    Liu X; Happel C; Ziegelbauer JM
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27852859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency.
    Ye FC; Zhou FC; Xie JP; Kang T; Greene W; Kuhne K; Lei XF; Li QH; Gao SJ
    J Virol; 2008 May; 82(9):4235-49. PubMed ID: 18305042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Degradation of TRIM32 is induced by RTA for Kaposi's sarcoma-associated herpesvirus lytic replication.
    Zhang Y; Dong Z; Gu F; Xu Y; Li Y; Sun W; Rao W; Du S; Zhu C; Wang Y; Wei F; Cai Q
    J Virol; 2024 Jun; 98(6):e0000524. PubMed ID: 38717113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kaposi's Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes.
    Host KM; Jacobs SR; West JA; Zhang Z; Costantini LM; Stopford CM; Dittmer DP; Damania B
    mBio; 2017 Oct; 8(5):. PubMed ID: 29018115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression.
    Sadagopan S; Sharma-Walia N; Veettil MV; Raghu H; Sivakumar R; Bottero V; Chandran B
    J Virol; 2007 Apr; 81(8):3949-68. PubMed ID: 17287275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis.
    Ramalingam D; Happel C; Ziegelbauer JM
    J Virol; 2015 Apr; 89(8):4249-61. PubMed ID: 25631082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
    Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
    J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.